OMPARATIVELY speaking, the morbidity and mortality rates associated with the rupture and treatment of aneurysms located in the anterior circulation carry a better prognosis than those in the posterior circulation.
This fact is partly due to the surgical difficulties related to BA bifurcation aneurysms. Unfortunately, aneurysms of the BA bifurcation are the most common in the posterior circulation (~ 50% of posterior circulation aneurysms, but only ~ 5% of all intracranial aneurysms). Microneurosurgical approaches are often challenging given that these lesions are deeply located, confined in a narrow anatomical space (the interpeduncular fossa), surrounded by important perforating arteries, and in close relation to the diencephalon, especially large and giant aneurysms. 10 Endovascular techniques have evolved significantly over the last three decades, with major improvements in angiography, microcatheter, and coil technologies, although the underlying principles involved in treating intracranial aneurysms through occlusion with metal coils were described long ago. 29 Within the last decade, in particular, endovascular coil occlusion of intracranial aneurysms has evolved from an experimental alternative to a widely accepted method. 28 Radiological and clinical results achieved with the use of detachable coils to obliterate aneurysms, particularly those arising at the BA tip, have been encouraging. 2 Endovascular coil occlusion carries relatively low morbidity and mortality rates, significantly reduces the risk of (re)bleeding, and allows for the safe implementation of aggressive measures intended to prevent delayed cerebral ischemia due to vasospasm. 15 More recently, analysis of large-scale randomized trials and data registries has revealed the clinical effectiveness of coil occlusion for ruptured as well as unruptured intracranial aneurysms. 17, 28 In the present study we aimed to compare the results of the endovascular procedures performed at a single institution, in terms of both safety and efficacy, with data published by other neuroendovascular teams.
Clinical Material and Methods
All data were collected at the Alfried Krupp Krankenhaus, a referral center for neuroendovascular services in Essen, Germany. Between November 6, 1992 , and February 12, 2005, a total of 2503 intracranial aneurysms in 2141 patients were treated using endovascular coil occlusion. Seventy-one percent of the lesions (1776 aneurysms) were situated in the anterior circulation and 29% (727 aneurysms) in the posterior circulation, including 316 BA bifurcation aneurysms treated with endovascular coil occlusion. All available data concerning these BA bifurcation aneurysms were analyzed for this study.
All data were entered into a database (Excel; Microsoft Corp., Redmond, WA) customized for our specific needs, including the following parameters: family name and first name; date of birth; date of first coil treatment; eventual clinical symptoms not related to SAH; presence of SAH; date of first through fourth SAH; clinical grade following SAH, according to the Hunt and Hess scale; 20 amount of subarachnoid blood detected on computerized tomography scanning and graded according to the Fisher classification scheme; 14 history of previous surgical and endovascular attempts; number of aneurysms; number of untreated aneurysms; presence of spontaneous aneurysmal thrombosis; administration of calcium channel blockers; presence of vasospasm; presence of external ventricular drainage; association of the aneurysm with an arteriovenous malformation or other vascular lesion; location of the aneurysm including anatomical origin and side; notation of previous rupture; fundus diameter; aneurysm neck width; presence of arterial dissection; presence of intraaneurysmal thrombosis; history of bypass surgery and direct surgery to the aneurysm; number of introduced coils; technical coil specifications and coil brand; degree of occlusion during the first treatment; administered medication and technique of endovascular treatment; presence of and countermeasures for treatment complications; resulting clinical status including any eventual deficit related to the endovascular procedure; final clinical status according to the GOS; 21 equivalent data sets for subsequent second through ninth treatment sessions; followup angiography data; degree of aneurysm occlusion found on angiography; reasons for eventual aneurysm recurrence together with data sets for the first through eighth followup examinations; and final clinical status according to the GOS, with the time of the complete individual follow up, status at follow up, and the date and evident cause of eventual death.
We focused our interest on the anatomical features of the BA bifurcation aneurysm, the technical aspects of treatment, and the anatomical and clinical results achieved by coil occlusion, both in the acute phase and during the midand long-term follow-up examinations. We interpreted therapeutic efficacy as the ability of endovascular treatment effectively to occlude the aneurysm, and safety by the frequency of technical complications and their clinical sequelae.
Results

Descriptive Statistics
In this series, 316 BA tip aneurysms in 314 patients were treated using endovascular coil occlusion. These aneurysms were solitary in 273 patients (86.9%); at least one additional aneurysm was detected in 41 patients.
A previous rupture of 210 aneurysms (66.5%) was confirmed, and six aneurysms (1.9%) may or may not have ruptured; these latter aneurysms were subsequently considered unruptured. One hundred aneurysms (31.6%) were unruptured and 23 (7.3%) of these caused nonhemorrhagic symptoms-usually cranial nerve palsy.
Note that for the purposes of our analysis, all BA tip aneurysms treated endovascularly were analyzed individually by aneurysm, not by patient.
The dimensions of the 316 embolized BA tip aneurysms were as follows: neck diameter: 4.9 mm (mean), 4 Ϯ 2.7 mm (median Ϯ SD); fundus diameter: 9.9 mm (mean); 8 Ϯ 6.1 mm (median Ϯ SD). In terms of the fundus size categories, the following distribution was noted: small (Ͻ 6 mm), 73 aneurysms (23.1%); medium (6-14 mm), 179 aneurysms (56.7%); large (15-25 mm), 53 aneurysms (16.8%); and giant (Ͼ 25 mm), 11 aneurysms (3.5%). One hundred seventy-two aneurysms (54.4%) had narrow necks (Յ 4 mm), and 144 (45.6%) had wide necks (Ͼ 4 mm).
No surgical treatment had been attempted in 298 of the BA tip aneurysms (94.3%); coils were placed in three aneurysms (1%) after incomplete clip application, in another three (1%) after wrapping, and in 12 (3.8%) after a failed surgical attempt. Clip application was not performed after endovascular coil occlusion in any aneurysm. The clinical statuses of patients with BA tip aneurysms are shown in Table 1 .
First Treatment Session
In the 210 ruptured aneurysms (66.5%) the median interval between hemorrhage and treatment was 4 days (minimal 0 days, maximal 26 years, mean 248 Ϯ 1072 days [SD] ).
Among the 316 BA tip aneurysms, a mean of 9.6 coils (median 7 coils, SD Ϯ 8.8 coils) were used at the first treatment session. In 110 aneurysms (34.8%) treatment included the use of a 3D coil; in 85 (26.9%) it involved fibered coils. The degree of occlusion after the first treatment session is shown in Table 2, whereas Table 3 summarizes complications encountered during the first treatment session. Patient outcomes after the first treatment session, according to the criteria of the GOS, are presented in Table 4 . In Table  5 , the clinical status before endovascular treatment (Hunt and Hess grade) is correlated with the clinical outcome (GOS). Table 6 shows the neurological statuses of patients after the first treatment session. 
Second Treatment Session
Forty-eight aneurysms (15.2%) were treated endovascularly during a second therapeutic session after significant residual or recurrent aneurysm perfusion had been confirmed on angiography studies. The time interval between the first and second treatments varied from 3 days to 9.2 years (mean 17 months, median 19 months, SD Ϯ 28 months). Four hundred three coils were placed during these 48 treatment sessions (mean 8.4 coils, median 6 coils, SD Ϯ 7 coils). In six (12.5%) of 48 sessions, treatment was begun using a 3D coil. Fibered coils as well as other types were inserted in 16 (33.3%) of the 48 BA tip aneurysms. The degree of occlusion achieved, complications encountered, and patient neurological status related to the second treatment session are presented alongside the respective data from the first treatment session in Tables 2, 3 , 4, and 6. Note that more than two treatment sessions were needed in 17 patients.
Angiography Follow Up
All conscious patients and/or available relatives were informed prior to the endovascular treatment about the need for one or several follow-up angiography examinations. Basically, we attempted to obtain angiography studies 12 and 24 months after the first and following treatment sessions in all patients. No patient was intentionally excluded from follow up in advance. Despite these efforts, the actual followup intervals varied widely from 3 days to 7.6 years, mostly because the patients were reluctant to visit at the proposed time. Table 7 summarizes the reasons for missing the angiography follow up in 136 (43.3%) of 314 patients.
At least one follow-up angiogram was obtained for 178 aneurysms (56.4%). The mean time interval between the first treatment and the first follow-up angiography study was 19.4 Ϯ 19 months (median 13.3 months). Ninety-five initial angiography follow ups were performed 12 or more months after treatment. A second angiographic follow up was performed to demonstrate the status of 80 aneurysms (25.3%). The time between the first and second angiography studies varied from 3 days to 9.7 years (mean 29.9 months, median 22.6 months, SD Ϯ 27.9 months). A third angiography examination was performed to observe 35 aneurysms (11.1%). The mean interval between the first treatment session and the third follow-up angiography ranged from 1.9 months to 11.4 years (mean 55.8 months, median 55.1 months, SD Ϯ 31.1 months). All occlusion rates and recurrences found at the first, second, and third angiography follow ups are shown in Table 8 . 
Correlative Statistics
Significantly lower rates of occlusion were achieved during the first treatment session in aneurysms with larger neck widths (p = 0.000, Kruskal-Wallis test) and larger fundus diameters (p = 0.000, Kruskal-Wallis test). Based on results obtained during the first follow-up angiography study, the occlusion rate was not significantly lower in ruptured aneurysms (p = 0.605, chi-square test), but was significantly dependent on the occlusion rate at the first treatment (p = 0.000, chi-square test). In 155 aneurysms with 90 to 100% occlusion as a result of the first treatment, the initial follow-up angiogram revealed this same rate of occlusion in 121 aneurysms (78.1%), whereas 34 lesions (21.9%) demonstrated an occlusion rate less than 90%. In four of 23 aneurysms with less than 90% occlusion after the first treatment, the first follow-up examination revealed complete occlusion. The occlusion rate at the first angiography follow up was dependent on the neck width (p = 0.000, Kruskal-Wallis test) and the fundus diameter (p = 0.000, Kruskal-Wallis test); these results are presented in Table 9 . The use of 3D (p = 0.263, chi-square test) or fibered coils (p = 0.146, chi-square test) had no obvious influence on the occlusion rate at the first angiographic follow up; neither was there any correlation between coil brand and occlusion rate (p = 0.350, chi-square test).
Discussion
Before the advent of the controlled detachable coil method, endovascular aneurysm treatment was mainly performed in a few highly specialized centers worldwide. Some of this accumulated experience is valuable today, despite all the improvements in catheters and endovascular devices. Since the introduction of electrolytically detachable coils into clinical practice in 1992, abundant literature on this topic has accumulated, although most of the published studies feature small series and are therefore prone to statistical fluctuations.
Incidence and Anatomy
Basilar artery bifurcation aneurysms account for 5 to 8% of all intracranial aneurysms. 31 From an endovascular perspective, the occlusion of aneurysms with detachable coils is less dependent on the lesion location than on its anatomical configuration. The straight course of the BA and the anatomical disposition of most BA tip aneurysms are favorable for endovascular navigation and aneurysm catheterization. The width of the aneurysm neck is the single most important feature and is related to the overall size of the fundus. Debrun and colleagues 8 reported that aneurysms with a dome/neck ratio of at least 2 and an absolute neck diameter less than 5 mm represented the ideal candidates for coil treatment. These features correlated with higher rates of complete occlusion as well as improved clinical outcomes. A high or deep location of the tip of the BA does not influence the endovascular treatment and does not require brain and/or cranial nerve retraction. Another advantage of endosaccular coil occlusion for aneurysms located in the BA tip is the reduced risk of compromising perforating vessels, because these vessels usually arise from the aneurysm neck and almost never from the sac. 10 This anatomical disposition allows tight coil packing of most BA tip aneurysms; however, sometimes BA bifurcation aneurysms enlarge and incorporate the ostia of posterior cerebral and/or superior cerebellar arteries. In this type of aneurysm, it is difficult to achieve complete occlusion. 3, 34 In contrast to surgical treatment, significant tortuosity or stenoses of the vertebral artery or BA represent potential obstacles to endovascular (47) 29 (62) 3 (6) 9 (19) 3 (7) 2 (4) IV (43) 20 (47) 5 (12) 6 (14) 5 (12) 6 (14) V (23) 3 (13) 2 (9) 8 (35) 4 (17) 5 (22) NA (12) 8 (67) 1 (8) 2 (17) 0 (0) 1 (8) 
treatment. In these circumstances, endovascular access to a BA tip aneurysm may require stent-assisted proximal vessel reconstruction.
In wide-necked BA tip aneurysms, the use of 3D coils, 5 a TriSpan device, 35 a self-expanding stent, 18 or a combination thereof 19 can be very helpful. These technical improvements apparently do not increase the stability of aneurysm occlusion, however. Wide-necked aneurysms in which primary coil occlusion was only possible with the use of a TriSpan device are especially prone to significant recurrence. Modified coils that may prevent recurrence are currently the focus of clinical evaluation. The stimulation of intraaneurysm fibrous tissue formation by polymer-coated coils 30 (Matrix; Target Therapeutics/Boston Scientific, Quincy, MA) and an increased filling rate by gel-coated coils 6 (Hydrocoil; MicroVention, Aliso Viejo, CA) are promising concepts as well. We observed a reduced aneurysm recurrence rate when using electrolytically detachable coils with attached nylon fibers. 24 
Aneurysm Rests and Postoperative Hemorrhage
It is generally accepted that the incomplete application of an aneurysm clip may result in recurrent hemorrhage and that aneurysm neck remnants or rests can enlarge. 9, 13 The same is basically true for incomplete coil occlusion of aneurysms. 4 The 11 postprocedural hemorrhages in this series confirm this premise in an alarming way.
Endovascular Coil Occlusion of BA Tip Aneurysms
Data from a prospective study featuring a comparison between surgical and endovascular treatment results of BA bifurcation aneurysms are not available. In the International Subarachnoid Aneurysm Trial, only 17 (0.7%) of 2143 studied aneurysms were located at the BA tip, which is a serious underrepresentation. 28 Given that enrollment into this study required any given aneurysm to be suitable for either treatment modality, the majority of centers excluded BA bifurcation aneurysms, because personnel were reluctant to operate on them in the event of random assignment to the surgical arm.
Data from several studies on the treatment of BA tip aneurysms with detachable coils have been published. 25 Table  10 summarizes the data from six such studies. 1, 15, 22, 27, 32, 34 In a systematic review of five published articles, Lozier and colleagues 25 collected data on the indications for endovascular therapy of 182 BA apex aneurysms. In 50.5% of the pa- 
* Clinical outcome data unavailable for three ruptured lesions. tients the indication for endovascular treatment was based on the anticipated surgical difficulty, 16.5% had undergone a failed surgical procedure, and 10.4% were in poor medical condition. Patient (9%) and physician (23%) preference were additional reasons for endovascular coil treatment. In the present series, we did not note the reasons a patient had been referred to our service for endovascular treatment. Given that the patients had been referred by many hospitals, differences in management and patient selection in these hospitals prevented us from controlling for these factors. Table 11 summarizes the clinical condition, according to the Hunt and Hess scale, in 226 patients who underwent endovascular coil occlusion of a BA tip aneurysm and whose data have been published in various reports.
Procedural Morbidity and Mortality Rates
The procedure-related morbidity rate in the literature was 6.6%, and the procedural mortality rate was 1.3%. Within 30 days of the procedure, 4.4% of the patients died. Among the patients with SAH, the reported rate of vasospasm was 16.9%. In our series we encountered a first-procedure morbidity rate of 5.4% and a mortality rate of 2.2%; both figures are within the range reported in the literature. The procedural morbidity rate following the second treatment was 4.2% (we found no comparable published data). Another 14 patients (4%) died of causes unrelated to the first procedure. Vasospasm was registered in 53 (22.5%) of 236 patients with SAH. This number is slightly higher than corresponding results from the literature, perhaps because of our comprehensive data registry. We noted vasospasm in all possible circumstances, for example, during angiography or at any time during the postprocedural course. We did not differentiate between angiographic and symptomatic vasospasm.
The complications encountered during the initial treatment of the 316 aneurysms included a failed attempt in 1.6%, periprocedural aneurysm rupture in 3.2%, coil malposition in 2.8%, thrombosis in 4.1%, and embolic events in 8.2%. The frequency of periprocedural aneurysm ruptures may reflect aggressiveness in the treatment approach, including the use of relatively stiff microcatheters, which allow more compact coil occlusion. The threshold for the recognition of thromboembolic events during and after treatment varies significantly between series. We did not perform regular magnetic resonance imaging examinations after coil treatments; although whenever this neuroimaging study was performed and demonstrated any kind of diffusion abnormality, an embolic event was noted. Even considering this method of data registry, an approximately 12% incidence of thromboembolic events is still far below the reported numbers. 33 The most important difference between the present study and previously published series is the number of treated patients: approximately 50 to 75% of the patients included in these studies were treated after aneurysm rupture. We were able to collect follow-up data at a mean of 42 months. Note that an independent lifestyle, noted in 77% of the patients in our series, was enjoyed by a greater percentage of patients in some of the other series. Nonetheless, complete occlusion was achieved in 61% of the patients in other studies, a rate similar to that in the present series. 17 Eleven aneurysmal SAHs following coil embolization were related to the large numbers of cases and the long follow-up interval, but nevertheless illustrate the critical importance of obtaining a high degree of occlusion during endovascular treatment, especially when follow-up examinations and eventual repeated treatment will not be performed in a controllable way.
Procedural morbidity and mortality rates are relatively high in our series. We believe the reasons to be multifactorial: patient selection at referral, therapeutic aggressiveness, and the involvement of several rather than one interventionalist may all be important. In addition, the long time period of the study (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) means that there has been a significant evolution in both the physician's experience and the available materials during the course of the study. The overall mortality rate of 6.7% is quite low, however, and is particularly surprising given that fewer patients with unruptured aneurysms and more patients with a poor Hunt and Hess grade (Grades IV and V) were included in our analysis compared with patients reported on in other publications. 25 
Angiography Results
The goal of any treatment for an intracranial aneurysm is its exclusion from the circulation. In various series in which detachable coils were used endovascularly to treat BA bifurcation aneurysms, complete occlusion rates varied between 21 and 84%. 1 In general, the degree of occlusion depends on many factors, although the size of the aneurysm and its neck width are the most predictive. Aneurysms with a large neck (Ͼ 4 mm) are more difficult to occlude completely because the neck does not keep the coils in place, which increases the risk of coil migration into the parent artery together with subsequent narrowing or occlusion of the vessel. 8 In a study on factors that might influence the long-term stability of angiographically proven results, Fernandez-Zubillaga and associates 12 found a close correlation between occlusion stability and aneurysm neck size. Narrow-necked aneurysms could be completely obliterated in 85% of the cases, whereas complete occlusion in wide-necked aneurysms was accomplished in only 15%. An aneurysm may have an actual neck width of less than 4 mm. Note, however, that if the fundus is also 4 mm or less, the neck may be considered wide for that aneurysm. Thus, the angle of the aneurysm neck in relation to the parent artery and not the actual neck size may determine whether the aneurysm will retain the coils. 23 Guglielmi and colleagues 16 presented the results of a multicenter study involving 42 patients harboring posterior circulation aneurysms treated with endovascular coil occlusion. Complete occlusion was achieved in only 17 aneurysms (40%); among these, four aneurysms (23%) had a wide neck (Ͼ 4 mm). In this series there were 26 BA tip aneurysms: 22 lesions (84%) were considered to be wide necked and four (16%) were small necked. Complete occlusion was achieved in only four (15%) of the 26 aneurysms. A relationship between neck width and aneurysm occlusion was observed given that total aneurysm obliteration was achieved in only one of 22 wide-necked aneurysms.
In a multicenter study of 150 GDC-treated BA bifurcation aneurysms, Eskridge and Song 11 noted that occlusion greater than 90% was achieved in 75% of the aneurysms. During a mean follow up of 13.7 months (range 0-43 months), the degree of occlusion remained stable (that is, Ͼ 90%) in 79% of the aneurysms.
In a series of 45 BA tip aneurysms, Bavinzski and coworkers 1 reported a 100% rate of occlusion in 30 lesions (67%), 90 to 99% in nine lesions (20%), and less than 90% in six lesions (13%). In large aneurysms, recanalization occurred in 57%, and some of the larger lesions required as many as four endovascular treatment sessions to achieve optimal occlusion. When narrow-necked aneurysms were analyzed as a subset, a stable angiography result was found in 92%.
Tateshima and associates 34 treated 75 BA tip aneurysms with coil embolization. The immediate anatomical results demonstrated complete or near-complete occlusion in 64 aneurysms (85%) and incomplete occlusion in seven (9%). Four aneurysms (5%) could not be treated. Recanalization occurred in one of five small aneurysms with wide necks, in four of 10 large aneurysms, and in four of eight giant aneurysms. One incompletely occluded giant aneurysm ruptured during the follow-up period. Raymond, et al., 32 embolized 31 BA bifurcation aneurysms. Final angiography studies demonstrated complete obliteration in 42% and residual neck or so-called dog-ears in 52%. During a mean follow up of 42 months, seven recurrences were noted, necessitating repeated coil treatment in five patients.
Lozier and colleagues 25 conducted a systematic review of the literature on BA tip aneurysms, consisting of 226 treated aneurysms. In this metaanalysis, the authors reported that the initial complete occlusion (100%) was successful in 43.2% of the lesions, 90 to 99% occlusion in 44.6%, and partial occlusion less than 90% in 12.3%. The comparative numbers in our series were 100% occlusion in 185 aneurysms (59%), 90 to 99% occlusion in 88 (28%), and less than 90% occlusion in 43 aneurysms (13%). The failure rate of endovascular treatment in the published cases was 3.5% (eight of 228 intent-to-treat cases). In our series, we counted five failed endovascular attempts (1.6%) in 316 aneurysms. Table 11 shows the clinical condition (Hunt and Hess grade) of 226 patients who underwent endovascular coil occlusion, as reported by Lozier, et al., and us in the present study.
Lusseveld and associates 26 compared the results of coil occlusion and clip application of BA bifurcation aneurysms. Both groups comprised 44 patients. A poor clinical outcome was observed in five patients (11%) treated endovascularly and in 13 patients (30%) treated using clip application. Procedural complications were more common in the surgical group, although the difference was not statistically significant. The rate of poor outcome, irrespective of the cause, was higher in our series. Sixty-one treated aneurysms (21%) were associated with an early clinical outcome equivalent to a GOS score of 1, 2, or 3. This result is even more surprising given that the series by Lusseveld, et al., included only ruptured aneurysms.
Vallée and colleagues 36 analyzed the results of the GDC treatment of 55 BA tip aneurysms. At the end of the initial procedure, occlusion was assessed in 52 aneurysms and rated as complete in 39 (75%), near complete in 12 (23%), and incomplete in one aneurysm (2%). Complete obliteration was achieved in 27 (96%) of 28 small-necked aneurysms, but in only 12 (50%) of 24 wide-necked lesions. In the present series, the only independent predictor of the initial occlusion rate and revascularization was aneurysm neck size.
Although every effort should be made to achieve dense coil packing, results of histopathological studies have shown that only approximately 30% of the saccular lumen of an aneurysm is actually filled with platinum coil material, even in cases of angiographically proven complete occlusion. In most circumstances, an occlusion rate of 90 to 100% should provide sufficient protection against bleeding. Partial occlusion at a rate between 50 and 90% could have some hemodynamic effects on the aneurysm, for instance, if the dome and fundus are covered with coils. In 98% of cases, the rupture site of a saccular aneurysm is located at the dome; only 2% of aneurysms rupture at the neck. 37 Available follow-up angiograms from 189 cases in the literature revealed 100% occlusion in 46.5%, 90 to 99% occlusion in 42.9%, and less than 90% occlusion in 10.6% of cases, with an inadequate follow up in 51 patients. We obtained angiographic follow-up data on only 178 aneurysms (56%). The mean interval between the first treatment and the first follow-up angiography was 21 months. These results are presented in Table 12 .
Data in the literature confirm a relationship between aneurysm neck size and the degree of occlusion on follow up, with a higher chance of recanalization occurring in widenecked aneurysms. 17 
Aneurysm Rebleeding After Coil Occlusion
Authors of previous reports have shown that incomplete occlusion of the aneurysm lumen, incomplete packing, coil compaction, or coil migration into the intraaneurysm thrombus may cause a recurrence and subsequent (re)bleeding. 7 In the literature review performed by Lozier and coworkers, 25 delayed SAH from coil-occluded BA tip aneurysms was reported in three cases during 5390 months of observation. This rate is equivalent to a 0.7% annual risk of bleeding from an aneurysm that has been subject to previous coil embolization. Nonetheless, this number is almost certainly an underestimate; one would expect the risk of hemorrhage from a 100% occluded aneurysm to be nil, and therefore only partially occluded aneurysms should be considered in this calculation because they are subject to a higher risk. In our series, we recognized 11 rebleeds from coil-occluded BA tip aneurysms during a cumulative follow-up period of 9846 months (821 years). This incidence is equivalent to a 1.3% annual risk of hemorrhage. If the 87 aneurysms with 100% occlusion at the first angiographic follow up are removed from this calculation, 6375 months (531.3 years) of cumulative follow up remain available. If the same number of rebleedings are considered in a cumulative follow-up period now reduced to 6375 months, the annual risk of bleeding in partially (Ͻ 100%) occluded aneurysms is 2.1%.
Byrne, et al., 4 reported annual rebleeding rates of 0.8% in the 1st year after treatment, 0.6% in the 2nd year, and 2.4% in the 3rd year in a series of 317 patients who had presented with SAH (46% BA tip aneurysms) and were followed up for a median of 22.3 months (range 6-65 months). Recurrent bleeding was related to one coincidental untreated aneurysm, to three recurrent aneurysms, and originated from one aneurysm with a stable but incomplete degree of occlusion on angiography.
Based on their observations, Feuerberg and colleagues 13 concluded that there is a difference between the natural history of postoperative aneurysm rests compared with that of untreated (un)ruptured aneurysms. They calculated an annual bleeding risk for aneurysm rests of 0.38 to 0.79% for an observation period ranging from 4 to 13 years. In the majority of patients, coil embolization affects at least permanent occlusion of the aneurysm dome and fundus, although neck remnants are a frequent finding. The procedural risk of repeated treatment must be weighed against the risk related to the reperfused portion of an aneurysm. On an individual basis, a decision in favor of a new treatment attempt will be straightforward in the case of a significant aneurysm recurrence. In many patients, however, the decision to treat an aneurysm remnant again or to wait and perform additional follow-up examinations is difficult; therefore, further data on both the risks of repeated treatment and the prognosis of aneurysm remnants are needed.
Mid-Term Outcome
The acute safety and efficacy of endovascular coil occlusion of intracranial aneurysms are widely accepted. 28 Nonetheless, the long-term stability of successful results is still a matter of controversy. The risks associated with postoperative aneurysm remnants have been documented in the neurosurgical literature. 13 In the systematic literature review by Lozier and associates, 25 84% of the patients were independent at the clinical follow up, 6.8% were dependent, and 9.5% had died. These figures were based on published data from 190 patients with a cumulative follow up of 4955 months and a mean follow up of 26 months per patient.
We obtained clinical follow-up data from 237 patients, with a cumulative follow up of 821 years. One hundred ninety-five (82%) of 237 patients were independent (GOS Score 5 or 4), 33 (13%) were dependent (GOS Score 3), 11 (4%) were in a vegetative state (GOS Score 2), and 48 (20.3%) were dead (GOS Score 1).
Limitations of This Study
Endovascular treatment was selected by the referring physician and/or the patient. During the later years included in the study, with the increasing popularity of endovascular treatment, many patients opted for aneurysm coil occlusion. Anticipated surgical difficulty and patient preference are vague criteria not driven by anatomical or surgical analysis of the individual circumstances.
Many cases represented in this study are unavoidably associated with several methodological limitations. Data were collected during an interval of more than 12 years when technically improved coils and microcatheters became available. Furthermore, six interventional neuroradiologists with different levels of experience and skills actively participated in the treatment of the patients. Neither the effect of technical progress nor the individual or institutional learning curve is controlled for. Nonetheless, because refined devices became available to all active interventional centers at more or less the same time, this accessibility should have influenced other endovascular centers in a similar way.
Data collection was arranged and supervised by the principal author (H.H.). Several physicians, medical students, and other coworkers participated in this process. No external monitoring was available; however, all patients were under the care of either neurologists or neurosurgeons not directly related to any of the authors of this paper. The patient records formed the basis for the clinical entry and outcome data presented here. More than one experienced endovascular practitioner reviewed all angiograms in separate sessions.
Future Perspectives
Despite the undoubtedly good clinical and anatomical results of endovascular coil occlusion of BA tip aneurysms, there is plenty of room for improvement. During the last decade, a series of technical advances have become available for routine clinical use. Among them, 3D-reconstructed digital angiography, braided microcatheters, 3D coils, and adjunctive devices such as the TriSpan coil and self-expanding microstents have proven helpful. Future efforts will concentrate on achieving as complete as possible occlusion during the first treatment session to avoid residual blood flow into the aneurysm as a major cause of later recurrence and/or hemorrhage. This problem may be addressed using modified coil surfaces such as expanding gel (Hydrocoil; Microvention, Inc.) or thrombogenic fibers (Sapphire; Dendron/MTI, Bochum, Germany). The formation of fibrous tissue within the aneurysm is stimulated by a coil surface made from biodegradable polymer (Matrix Coil; Target Therapeutics/Boston Scientific). Bridging the aneurysm neck with a permanent stent instead of a temporary balloon has become less hazardous since the introduction of selfexpanding Nitinol stents (Neuroform; Target Therapeutics/ Boston Scientific). Liquid agents for balloon-assisted occlusion of aneurysms have been incorporated into clinical practice (Onyx; Micro Therapeutics, Inc., Irvine, CA). This technique obviously requires further refinement, but the underlying concept is promising.
Apart from these technical advances, further data collection in those patients treated during the last decade are required to better understand the factors that determine longterm success or failure. For instance, little is known about the natural history of the minor neck remnants frequently found on follow-up angiograms obtained after coil treatment. We assume that some of the treatments we perform for recurrences today may be unnecessary. Bearing in mind the frequently disastrous consequences of rebleeding, however, residual flow into an aneurysm is always a matter of concern.
Conclusions
The clinical outcome in such a large series of patients following endovascular coil occlusion of BA tip aneurysms confirms both the safety and efficacy of this treatment modality. Further improvements must address the treatment of very wide-necked and fusiform aneurysms. The long-term stability of a first occlusion remains a cause for concern. Rigorous angiographic follow-up studies and, in the case of recurrent flow into the aneurysm, effective repeated treatment are mandatory in preventing patients from aneurysm (re)hemorrhage.
